Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 1 July 2019. Rick Gonzalez.

Executive Summary

AbbVie is set to enter the medical aesthetics space with its surprise announcement to buy Allergan for about $63bn in a cash and stock transaction. See what AbbVie's CEO Rick Gonzalez said about it here.

"With increasing interest and acceptability of aesthetic procedures and products globally and increasing utilization within younger demographics, the medical aesthetics market has the potential to double by 2025, making this franchise extremely attractive and durable for AbbVie." – Rick Gonzalez, CEO, AbbVie

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT125300

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel